Trading Signals: ABBV Stock Price Prediction and Forecast (Mon. Mar. 17, 2014 - Fri. Dec. 22, 2023)(AbbVie Inc.)
| ABBV latest price $149.2500 (-1.56%) ($148.4500 - $151.5100) on Wed. May. 3, 2023. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 1.48% (three month average) | RSI | 31 | Latest Price | $149.2500(-1.56%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | ABBV declines -1.6% a day on average for past five trading days. | Weekly Trend | ABBV declines -3.4% a week on average for past two weeks. | Market Behavior | Broad based sell-off for large cap. Growth stock rally for small cap. | Correlated ETFs | Broad market will support ABBV advance at 0% a week (0% probability) IBB(15%) XOP(15%) XBI(14%) XLE(12%) IWC(11%) | Factors Impacting ABBV price | ABBV will decline at least -0.74% in a week (0% probabilities). XLC(-23%) EDOC(-21%) VUG(-13%) BWX(-13%) XLK(-12%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -0.74% (StdDev 1.48%) | Hourly BBV | -1.8 () | Intraday Trend | -1.2% | | | |
|
Resistance Level | $158.95 | 5 Day Moving Average | $150.91(-1.1%) | 10 Day Moving Average | $156.63(-4.71%) | 20 Day Moving Average | $158.95(-6.1%) | To recent high | -9.5% | To recent low | 3.2% | Market Cap | $263.319b | | | | AbbVie, Inc. is a research-based biopharmaceutical company, which engages in the development and sale of pharmaceutical products. It focuses on treating conditions such as chronic autoimmune diseases in rheumatology, gastroenterology and dermatology; oncology, including blood cancers; virology, including hepatitis C virus (HCV) and human immunodeficiency virus (HIV); neurological disorders, such as as well as Parkinson's disease; metabolic diseases, comprising thyroid disease and complications associated with cystic fibrosis; pain associated with endometriosis; and other serious health conditions. The company was founded on October 19, 2011 and is headquartered in North Chicago, IL. |